Active Pharmaceutical Ingredients (API) Market Segmentation by Type (Generic, and Innovative); by Synthesis Type (Synthetic, and Biotech); by Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Musculoskeletal Disorders, Respiratory Diseases, and Other Therapeutic Applications); by Business Mode (Captive, and Merchant)-Global Demand Analysis & Opportunity Outlook 2020-2030

  • Product Code:
    RP-ID-10352347
  • Published Date:
    27 Jan 2022
  • Region:
    Global
  • Pages:
    170
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-54

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

The Research Report is Updated with 2020 Base Year, 2021 Estimated year and Forecast till 2030 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2020 as base year, 2021 as estimated year and forecast to 2030. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Global Active Pharmaceutical Ingredients (API) Market Highlights Over 2020 - 2030

The global active pharmaceutical ingredients (API) market is estimated to garner a revenue of USD 331.37 Billion by the end of 2030, by growing at a CAGR of 6.08% over the forecast period, i.e., 2021 – 2030. Moreover, the market generated a revenue of USD 185.23 Billion in the year 2020. The growth of the market can be attributed to the growing concern for the rising prevalence of chronic diseases worldwide, which is driving the need to develop advanced medications to treat these diseases. According to the statistics by the World Health Organization (WHO), in the year 2019, around 17.9 Million people died from cardiovascular diseases (CVDs). Additionally, in the other statistics by the WHO, in the year 2019, around 1.5 Million deaths were caused due to diabetes, while, in the year 2020, cancer accounted for around 10 Million deaths. To treat these chronic diseases specialized drugs are required, which is driving the need for APIs amongst the pharmaceutical drug manufacturers.

 

Active Pharmaceutical Ingredients (API) Market Research

 

CLICK TO DOWNLOAD SAMPLE REPORT

 

The growth of the market can also be attributed to the increasing demand for generic drugs, backed by the increasing number of generic drug approvals worldwide by governmental authorities. Besides this, the increasing advancements in healthcare, backed by the rising healthcare expenditure, is also expected to create numerous opportunities for the growth of the market. Additionally, the rising focus on the development of precision medicines, along with the rising demand for biosimilar drugs and the emergence of highly potency APIs (HPAPIs) are some of the opportunities anticipated to boost the market growth in the years to come.

Global Active Pharmaceutical Ingredients (API) Market Regional Synopsis

Regionally, the global active pharmaceutical ingredients (API) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is anticipated to garner the largest revenue of USD 127.61 Billion by the end of 2030, up from a revenue of USD 71.70 Billion in the year 2020. The growth of the market in the region can be attributed to the presence of a strong healthcare network, along with the rising healthcare expenditure. Moreover, increasing prevalence of chronic diseases in the region, especially in the United States, which according to the statistics by the Centers for Disease Control and Prevention (CDC) recorded having a chronic disease among 6 adults out of 10 adults, and two or more chronic diseases among 4 adults out of 10 adults. The market in the region can further be segmented by country into the United States and Canada. Out of these, the market in the United States is expected to garner the largest revenue by the end of 2030 and also grow with the highest CAGR of 6.03% during the forecast period. On the other hand, the market in the Asia Pacific is anticipated to garner the second-largest revenue of USD 104.98 Billion by the end of 2030. The market in the region is further segmented by country into Japan, Australia, Singapore, South Korea, India, China, and the Rest of Asia Pacific. Out of these, the market in China is projected to generate the largest revenue of USD 36.90 Billion by the end of 2030.

Growth Drivers and Challenges Impacting the Growth of the Global Active Pharmaceutical Ingredients (API) Market

Growth Drivers

  • Rising Prevalence of Chronic and Infectious Diseases Worldwide

  • Increasing Demand for Generic Drugs

Challenges

  • High Cost of Manufacturing of APIs

Global Active Pharmaceutical Ingredients (API) Market Segmentation Synopsis

The global active pharmaceutical ingredients (API) market is segmented by type into generic, and innovative, out of which, the generic segment is projected to grow with the highest CAGR of 6.28% during the forecast period. Further, by synthesis type, the market is segmented into synthetic and biotech, out of which, the synthetic segment is projected to garner the largest revenue by the end of 2030. By therapeutic application, the market is segmented into communicable disease, oncology, diabetes, cardiovascular disease, musculoskeletal disorders, respiratory disorders, and other therapeutic applications. Out of these, the cardiovascular disease segment is anticipated to garner the largest revenue of USD 68.81 Billion by the end of 2030, up from a revenue of USD 39.50 Billion in the year 2020. Additionally, by business mode, the market is segmented into captive and merchant, out of which, the merchant segment is expected to grow with the highest CAGR of 6.22% during the forecast period.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global active pharmaceutical ingredients (API) market that are included in our report are Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi-aventis Groupe, Boehringer Ingelheim International GmbH, Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd., API Corporation, Bristol-Myers Squibb Company, KATSURA CHEMICAL CO., LTD., and others.

Latest Developments in the Global Active Pharmaceutical Ingredients (API) Market:

  • May 18th, 2021: Novartis AG announced that its Sandoz division would expand the production capabilities in Kundl, Austria and in Palafolls, Spain. This step of the company is aligned with its plans which was proposed in July 2020, in a collaboration with the Austrian government, that focuses on investing more than USD 118 Million in the first step, for introducing a new manufacturing technology for the production of an API, oral amoxicillin, for its leading penicillin product.

  • June 16th, 2017: Bristol-Myers Squibb Company announced that it has signed a definitive purchase agreement with SK Biotek Co., Ltd., where the latter would purchase the small molecule active pharmaceutical ingredient (API) manufacturing facility of Bristol-Myers Squibb, located in Swords, Ireland.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.

  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.

  • The report includes detailed company profiles of the major players dominating the market.

  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.

  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

FREQUENTLY ASKED QUESTIONS

1.      Market Definition

1.1.  Definition

1.2.Market Segmentation

2.    Assumptions and Acronyms

3.    Research Methodology

3.1.Research Process

3.2.                    Primary Research

3.3.                    Secondary Research

4.    Executive Summary-Global Active Pharmaceutical Ingredients (API) Market

5.     Market Dynamics

5.1. Market Drivers

5.2.                     Market Trends

6.    Key Market Opportunities

7.     Major Roadblocks for the Market Growth

8.    Regulatory and Standards Landscape

9.    Industry Risk Analysis

10.            Pricing Analysis of Active Pharmaceutical Ingredients (API) Market

11.  Industry Value Chain Analysis

12.Trade Outlook

12.1.                  Import

12.2.                Export

13.Impact of COVID-19 on the Active Pharmaceutical Ingredients (API) Market

14.Product Feature Analysis

15. Competitive Positioning

16.Competitive Structure

16.1.                  Market Share Analysis, 2020

16.2.                Competitive Benchmarking

16.3.                Company Profiles

16.3.1.                      Pfizer Inc.

16.3.2.                    GlaxoSmithKline plc

16.3.3.                    Novartis AG

16.3.4.                    Sanofi-aventis Groupe

16.3.5.                     Boehringer Ingelheim International GmbH

16.3.6.                    Aurobindo Pharma

16.3.7.                     Dr. Reddy’s Laboratories Ltd.

16.3.8.                    API Corporation

16.3.9.                    Bristol-Myers Squibb Company

16.3.10.                KATSURA CHEMICAL CO., LTD.

17. Global Active Pharmaceutical Ingredients (API) Market Outlook

17.1.                  Market by Value (USD Billion)

17.2.                 Market Segmentation

17.2.1.                      By Type

17.2.1.1.    Generic, 2020-2030F (USD Billion)

17.2.1.2.  Innovative, 2020-2030F (USD Billion)

17.2.2.                     By Synthesis Type

17.2.2.1.  Synthetic, 2020-2030F (USD Billion)

17.2.2.2. Biotech, 2020-2030F (USD Billion)

17.2.3.                     By Therapeutic Application

17.2.3.1.  Communicable Diseases, 2020-2030F (USD Billion)

17.2.3.2. Oncology, 2020-2030F (USD Billion)

17.2.3.3. Diabetes, 2020-2030F (USD Billion)

17.2.3.4. Cardiovascular Disease, 2020-2030F (USD Billion)

17.2.3.5. Musculoskeletal Disorders, 2020-2030F (USD Billion)

17.2.3.6. Respiratory Diseases, 2020-2030F (USD Billion)

17.2.3.7. Other Therapeutic Applications, 2020-2030F (USD Billion)

17.2.4.                     By Business Mode

17.2.4.1.  Captive, 2020-2030F (USD Billion)

17.2.4.2. Merchant, 2020-2030F (USD Billion)

17.2.5.                     By Region

17.2.5.1.   North America, 2020-2030F (USD Billion)

17.2.5.2. Europe, 2020-2030F (USD Billion)

17.2.5.3. Asia Pacific, 2020-2030F (USD Billion)

17.2.5.4. Latin America, 2020-2030F (USD Billion)

17.2.5.5.  Middle East & Africa, 2020-2030F (USD Billion)

18.North America Active Pharmaceutical Ingredients (API) Market Outlook

18.1.                  Market by Value (USD Billion)

18.2.                Market Segmentation

18.2.1.                      By Type

18.2.1.1.   Generic, 2020-2030F (USD Billion)

18.2.1.2.  Innovative, 2020-2030F (USD Billion)

18.2.2.                    By Synthesis Type

18.2.2.1.  Synthetic, 2020-2030F (USD Billion)

18.2.2.2.                        Biotech, 2020-2030F (USD Billion)

18.2.3.                    By Therapeutic Application

18.2.3.1.  Communicable Diseases, 2020-2030F (USD Billion)

18.2.3.2.                        Oncology, 2020-2030F (USD Billion)

18.2.3.3.                        Diabetes, 2020-2030F (USD Billion)

18.2.3.4.                        Cardiovascular Disease, 2020-2030F (USD Billion)

18.2.3.5. Musculoskeletal Disorders, 2020-2030F (USD Billion)

18.2.3.6.                        Respiratory Diseases, 2020-2030F (USD Billion)

18.2.3.7. Other Therapeutic Applications, 2020-2030F (USD Billion)

18.2.4.                    By Business Mode

18.2.4.1.  Captive, 2020-2030F (USD Billion)

18.2.4.2.                        Merchant, 2020-2030F (USD Billion)

18.2.5.                     By Country

18.2.5.1.  United States, 2020-2030F (USD Billion)

18.2.5.2. Canada, 2020-2030F (USD Billion)

19.Europe Active Pharmaceutical Ingredients (API) Market Outlook

19.1.                  Market by Value (USD Billion)

19.2.                Market Segmentation

19.2.1.                      By Type

19.2.2.                    By Synthesis Type

19.2.3.                    By Therapeutic Application

19.2.4.                    By Business Mode

19.2.5.                     By Country

19.2.5.1.  United Kingdom, 2020-2030F (USD Billion)

19.2.5.2. Germany, 2020-2030F (USD Billion)

19.2.5.3. Italy, 2020-2030F (USD Billion)

19.2.5.4. France, 2020-2030F (USD Billion)

19.2.5.5. Spain, 2020-2030F (USD Billion)

19.2.5.6. Russia, 2020-2030F (USD Billion)

19.2.5.7. Netherlands, 2020-2030F (USD Billion)

19.2.5.8. Rest of Europe, 2020-2030F (USD Billion)

20.          Asia Pacific Active Pharmaceutical Ingredients (API) Market Outlook

20.1.                Market by Value (USD Billion)

20.2.              Market Segmentation

20.2.1.                    By Type

20.2.2.                  By Synthesis Type

20.2.3.                  By Therapeutic Application

20.2.4.                  By Business Mode

20.2.5.                   By Country

20.2.5.1.                        Japan, 2020-2030F (USD Billion)

20.2.5.2.                       Australia, 2020-2030F (USD Billion)

20.2.5.3.                       Singapore, 2020-2030F (USD Billion)

20.2.5.4.                       South Korea, 2020-2030F (USD Billion)

20.2.5.5.                       India, 2020-2030F (USD Billion)

20.2.5.6.                       China, 2020-2030F (USD Billion)

20.2.5.7.                       Rest of Asia Pacific, 2020-2030F (USD Billion)

21.Latin America Active Pharmaceutical Ingredients (API) Market Outlook

21.1.                  Market by Value (USD Billion)

21.2.                Market Segmentation

21.2.1.                      By Type

21.2.2.                    By Synthesis Type

21.2.3.                    By Therapeutic Application

21.2.4.                    By Business Mode

21.2.5.                     By Country

21.2.5.1.  Brazil, 2020-2030F (USD Billion)

21.2.5.2. Argentina, 2020-2030F (USD Billion)

21.2.5.3. Mexico, 2020-2030F (USD Billion)

21.2.5.4. Rest of Latin America, 2020-2030F (USD Billion)

22.           Middle East & Africa Active Pharmaceutical Ingredients (API) Market Outlook

22.1.                Market by Value (USD Billion)

22.2.               Market Segmentation

22.2.1.                    By Type

22.2.2.                   By Synthesis Type

22.2.3.                   By Therapeutic Application

22.2.4.                   By Business Mode

22.2.5.                   By Country

22.2.5.1. GCC, 2020-2030F (USD Billion)

22.2.5.2.                       Israel, 2020-2030F (USD Billion)

22.2.5.3.                       South Africa, 2020-2030F (USD Billion)

22.2.5.4.                       Rest of Middle East & Africa, 2020-2030F (USD Billion)

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
  1. Pfizer Inc.
  2. GlaxoSmithKline plc
  3. Novartis AG
  4. Sanofi-aventis Groupe
  5. Boehringer Ingelheim International GmbH
  6. Aurobindo Pharma
  7. Dr. Reddy’s Laboratories Ltd.
  8. API Corporation
  9. Bristol-Myers Squibb Company
  10. KATSURA CHEMICAL CO., LTD.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports